323 Union Ave., Rutherford, NJ 07070

PH: 201-933-4440

Website:  CalmareTherapyNJ.com  /  Email: CalmareNJ@gmail.com

About:

Rutherford Allied Medical Group and Calmare Therpy NJ USA are comprised of board certified doctors, chiropractic physicians and physical therapists who treat pain biophysically, without medication.

Our collective goal is to help patients dramatically improve their quality of life by alleviating several types of diagnosed, treatment-resistant chronic pain.

 Practice Biographies: https://calmaretherapynj.com/about-us/

Press Inquiries and Interview Requests:

Stephanie Duncan, MPW Communications, Inc.

O: 732.617.9296  /  C: 732.763.1866  / Email: stephanie@mpwcomm.com

Calmare Therapy NJ USA:

Calmare Therapy is a non-invasive, non-pharmaceutical solution for pain control and drug resistant pain. It uses biophysical “scrambler” technology, a type of treatment for nerve pain that uses electrodes placed on the skin. Very low doses of electricity are transmitted from the electrodes through the skin to block the pain.  Key points:

  • Cleared by the FDA and European CE mark-certified
  • Pain free
  • Drug-free
  • No side affects
  • It has been proven successful in the treatment of pain by leading research and medical studies.

How does Calmare work?

Calmare can relieve pain directly at the pain site without any reliance on medication. Via small electrodes, a ‘no-pain’ message is transmitted directly to the nerve for a period of about 35 minutes, on average. Regardless of severity, pain symptoms can be significantly lesened or even alleviated during the treatment series process. A full treatment process consists of one daily treatment for 10 days.

 What medical conditions are appropriate for Calmare Treatment?

Chronic pain / intractable pain including CRPS / RSD, post-herpetic neuralgia (PHN – complication from a shingles infection); chemotherapy-induced peripheral neuropathy (CIPN); diabetic nerve pain; post-surgical pain; phantom limb syndrome.

Calmare FAQS          

File: Updated 2/2017

Advertisements